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Introduction {#sec1-1}
============

Reynolds and Weiss isolated stem cells from the forebrain of an adult mammal in 1992 (Reynolds and Weiss, 1992), and not long after, neural stem cells (NSCs) were isolated from humans (Svendsen et al., 1998; Vescovi et al., 1999). It is now well-accepted that neurons derived from NSCs continue to form throughout adult life. Additionally, most mammals, including humans, undergo lifelong neurogenesis (Eriksson et al., 1998). NSCs can differentiate into astrocytes, neurons and oligodendrocytes, and possess an unlimited capacity for self-renewal that persists throughout the life of the animal (McKay, 1997; Seaberg and van der Kooy, 2002).

A rapid increase in stem cell research has been observed since the beginning of the 21^st^ century. Bibliometrics has been widely used to map the literature on stem cell research. A series of bibliometric analyses of stem cell-related research and applications have been conducted for nervous system diseases such as spinal cord injury, epilepsy (Yin et al., 2012), Parkinson's disease (Li, 2012) and cerebral ischemia. More recently, researchers have endeavored to clarify the cytology, physiology, metabolism and application of human NSCs (hNSCs) (Wang et al., 2018). However, the literature on hNSCs has not yet been systematically studied. Therefore, in the present study, we used bibliometric analysis to identify the research trends associated with hNSCs. Bibliometry allows the deciphering and quantitative analysis of the hot topics in the published literature. Hot topics can be identified by techniques such as co-word analysis and co-citation analysis (Yao et al., 2014). Particularly, co-word analysis, which can estimate the relationship between two professional words in related papers, has been most commonly used (Hong et al., 2014). In this study, the extracted professional words were classified using biclustering analysis, which can cluster lines and columns simultaneously (Hartigan, 1972) and perform a partial analysis from a large amount of data. In addition, the relationships between the themes and evolutionary trends were studied by social network analysis and strategic diagram (Zhang et al., 2013). In this way, in addition to journals, countries and influential publications, we also analyzed the internal relationships, characteristics, knowledge structures and theme trends of the NSC-related literature published from 2013 to 2018. Research status and emerging issues were mapped by biclustering analysis on the basis of co-occurring MeSH terms and strategic diagram. In addition, social network analysis was performed to visualize the knowledge structure and relationships between hNSCs and their cytology, physiology, genetics and clinical applications.

Data and Methods {#sec1-2}
================

Data resource and search strategy {#sec2-1}
---------------------------------

We retrieved and downloaded data from the PubMed database of the US National Center for Biotechnology Information. Medical Subject Heading (MeSH) terms, the medical vocabulary resource created by the National Library of Medicine, is the basis for Index Medicus and the MEDLINE database, and is used for indexing and cataloging articles in the PubMed system. For retrieval, articles were restricted to publication type as Journal Article, species as Humans, and language as English. "Neural Stem Cells" \[MeSH\] was used as the retrieval term. A total of 2742 articles published from 1 January 2013 to 31 December 2018 were retrieved. Every downloaded publication contained author, title, country, institution, MeSH terms and publication year, saved in XML format.

Data extraction and bibliographic matrix building {#sec2-2}
-------------------------------------------------

The bibliographic data were extracted from the PubMed database. The co-occurrence matrices and the term--source article relationships were created using Bibliographic Item Co-Occurrence Matrix Builder (Li et al., 2015). The contributive characteristics of the countries, journals, publication years and main MeSH terms/subheadings were analyzed using the Bibliographic Item Co-Occurrence Matrix Builder. In addition, the amount of high-frequency main MeSH terms/subheadings was defined by the threshold value (T), which can be expressed as: T = ![](NRR-14-1823-g002.jpg), where i represents the amount of main MeSH terms/subheadings appearing just once (Donohue, 1974). Therefore, the amount of high-frequency main MeSH terms/subheadings was defined according to this expression.

Biclustering analysis of high-frequency main MeSH terms/subheadings {#sec2-3}
-------------------------------------------------------------------

The high-frequency main MeSH terms/subheadings and PubMed Unique Identifiers of the hNSC-related literature retrieved from PubMed were subjected to biclustering analysis. The main MeSH terms/subtitles were classified according to the term-source article matrix.

Mountain Visualization was performed, and a visual matrix was built with the repeated bisection method in gCLUTO software (Rasmussen and Karypis, 2004). The peaks in the 3-D terrain are marked by numbers, which represent the clusters analyzed by biclustering. The color, height, volume and location of each peak in the figure were used to illustrate the data for the associated clusters. The relative location of each peak in the figure is the most informative attribute. The internal resemblance of a cluster is represented by the height of each peak. The relative resemblance of a pair of peaks is represented by the distance between them. The number of main MeSH terms/subheadings is proportional to the volume of a peak. Finally, the internal standard deviation of the objects in a cluster is shown by the peak color. Blue denotes high deviation, while red indicates low deviation. For the matrix visualization, the high-frequency main MeSH terms/subheadings are represented by the row labels, and the PubMed Unique Identifiers of source articles are indicated by the column labels, which are located on the left and top of the matrix, respectively. Based on the results of biclustering analysis, the structures of related research focuses were presented and analyzed.

Strategic diagram analysis {#sec2-4}
--------------------------

Based on theme centrality and density, a two-dimensional strategic diagram was built by drawing themes along two axes (Viedma-Del-Jesus et al., 2011). The external cohesion index or centrality, which indicates the central location of the subject in the frame, is represented by the X-axis. Furthermore, the internal cohesion index or density is represented by the Y-axis (Li et al., 2009). Four quadrants were generated by the two axes, and the clusters of main MeSH terms/subheadings were distributed to the four quadrants according to the results of biclustering analysis, constructing with GraphPad Prism 5 software (GraphPad Software Inc., San Diego, CA, USA).

Social network analysis {#sec2-5}
-----------------------

The social network analysis network was established using Ucinet 6.0 software (Analytic Technologies, Louisville, KY, USA) according to the co-occurrence matrix of high-frequency main MeSH terms/subheadings. Subsequently, the knowledge structures in the field of hNSCs were interpreted by social network analysis. The networks of main MeSH terms/subheadings were visualized and presented in two-dimensional maps using NetDraw 2.084 software (Analytic Technologies Co.). The main MeSH terms/subheadings network was represented by nodes, with the co-occurrence frequency shown by the links. The locations of main MeSH terms/subheadings were assessed by measuring the three centralities of each node (*i.e*., closeness, betweenness and degree) to gain an understanding on the network structure of hNSCs.

Results {#sec1-3}
=======

Characteristics of hNSC-related publications {#sec2-6}
--------------------------------------------

From 2013 to 2018, a total of 2742 papers met the search criteria mentioned above. The number of hNSC-related papers was 489 in 2013, increased to 519 in 2014, and peaked at 558 in 2016, with slight reductions in 2015 (481) and 2017 (522) (**[Figure 1A](#F1){ref-type="fig"}**). The United States made the largest contribution to hNSC-related studies, accounting for 54.05% of the published papers. England and the Netherlands ranked second and third, respectively, in the number of papers (**[Figure 1B](#F1){ref-type="fig"}**).

![Characteristics of human neural stem cell-related publications.\
(A) The number of publications on human neural stem cells from 2013 to 2018. (B) The number of publications from the top 15 countries. (C) The number of publications in the top 15 journals.](NRR-14-1823-g003){#F1}

*PLoS One* (impact factor (IF) = 2.766, 2017) published the greatest number of hNSC-related articles (130, 4.741%), followed by *Stem Cell Reports* (73, 2.662%) (IF = 6.537, 2017) and *Scientific Reports* (61, 2.225%) (IF = 4.122, 2017). The top-ranking 15 journals are shown in **[Figure 1C](#F1){ref-type="fig"}**.

Hot research topics based on MeSH term clusters {#sec2-7}
-----------------------------------------------

Among the hNSC-related literature, high-frequency main MeSH terms/subheadings had a cumulative frequency of 40.7962% (**[Additional Table 1](#T1){ref-type="table"}**), and were thus considered hot research topics over the past 6 years. The MeSH terms in this 6-year period were analyzed, and five clusters were identified by biclustering analysis (**[Figure 2](#F2){ref-type="fig"}**). The mountain and matrix visualizations of the main MeSH terms/subheadings are shown in **[Figure 2](#F2){ref-type="fig"}**. As suggested by the results, 78 high-frequency main MeSH terms/subheadings (**[Additional Table 1](#T1){ref-type="table"}**) were classified into five clusters. The 78 high-frequency main MeSH terms/subheadings are presented in **[Figure 2](#F2){ref-type="fig"}** (right side), showing the terms in reference to each cluster. The hierarchical trees on the left and top represent the relationships between high-frequency main MeSH terms/subheadings and between articles, respectively. Furthermore, the representative papers in each cluster were explored by identifying and summarizing the themes. The results of cluster analysis from the high-frequency main MeSH terms/subheadings of hNSC-related studies are given in **[Table 1](#T2){ref-type="table"}**.

###### 

High-frequency MeSH terms/MeSH subheadings from the included articles on human neural stem cells

  -----------------------------------------------------------------------------------------------------------------------
  Rank.   Major MeSH terms/MeSH subheadings         Frequency   Proportion of frequency (%)   Cumulative percentage (%)
  ------- ----------------------------------------- ----------- ----------------------------- ---------------------------
  1       Neural Stem Cells/cytology                644         4.8744                        4.8744

  2       Neural Stem Cells/metabolism              551         4.1705                        9.0448

  3       Neural Stem Cells/physiology              351         2.6567                        11.7015

  4       Neurogenesis/physiology                   336         2.5431                        14.2446

  5       Neural Stem Cells/transplantation         259         1.9603                        16.2050

  6       Cell Differentiation/physiology           226         1.7106                        17.9155

  7       Neural Stem Cells/drug effects            177         1.3397                        19.2552

  8       Stem Cell Transplantation/methods         163         1.2337                        20.4889

  9       Neurons/cytology                          123         0.9310                        21.4199

  10      Induced Pluripotent Stem Cells/cytology   122         0.9234                        22.3433

  11      Neural Stem Cells/pathology               98          0.7417                        23.0851

  12      Neurons/metabolism                        90          0.6812                        23.7663

  13      Cell Differentiation/genetics             67          0.5071                        24.2734

  14      Neurons/physiology                        66          0.4995                        24.7729

  15      Neurogenesis/genetics                     63          0.4768                        25.2498

  16      Neurogenesis/drug effects                 62          0.4693                        25.7190

  17      Cell Differentiation/drug effects         61          0.4617                        26.1807

  18      Cell Proliferation/physiology             57          0.4314                        26.6122

  19      Signal Transduction/physiology            57          0.4314                        27.0436

  20      Gene Expression Regulation,\              55          0.4163                        27.4599
          Developmental                                                                       

  21      Brain/metabolism                          54          0.4087                        27.8686

  22      Glioblastoma/pathology                    54          0.4087                        28.2773

  23      Brain/cytology                            52          0.3936                        28.6709

  24      Induced Pluripotent Stem\                 52          0.3936                        29.0645
          Cells/metabolism                                                                    

  25      Pluripotent Stem Cells/cytology           52          0.3936                        29.4581

  26      Spinal Cord Injuries/therapy              51          0.3860                        29.8441

  27      Cell Movement/physiology                  51          0.3860                        30.2301

  28      Cell Culture Techniques/methods           49          0.3709                        30.6010

  29      MicroRNAs/genetics                        45          0.3406                        30.9416

  30      Embryonic Stem Cells/cytology             45          0.3406                        31.2822

  31      Neural Stem Cells/virology                44          0.3330                        31.6152

  32      MicroRNAs/metabolism                      41          0.3103                        31.9255

  33      Brain Neoplasms/pathology                 40          0.3028                        32.2283

  34      Stroke/therapy                            39          0.2952                        32.5235

  35      Nerve Tissue Proteins/metabolism          36          0.2725                        32.7959

  36      Induced Pluripotent Stem\                 35          0.2649                        33.0609
          Cells/physiology                                                                    

  37      Transcription Factors/metabolism          33          0.2498                        33.3106

  38      Mesenchymal Stem Cells/cytology           32          0.2422                        33.5528

  39      Neurons/drug effects                      32          0.2422                        33.7950

  40      Neoplastic Stem Cells/pathology           32          0.2422                        34.0372

  41      Tissue Engineering/methods                30          0.2271                        34.2643

  42      Oligodendroglia/metabolism                29          0.2195                        34.4838

  43      Cell Proliferation/drug effects           29          0.2195                        34.7033

  44      Brain/pathology                           29          0.2195                        34.9228

  45      Embryonic Stem Cells/metabolism           28          0.2119                        35.1347

  46      Neural Crest/cytology                     27          0.2044                        35.3391

  47      Astrocytes/cytology                       27          0.2044                        35.5434

  48      Neoplastic Stem Cells/metabolism          27          0.2044                        35.7478

  49      Cellular Reprogramming                    26          0.1968                        35.9446

  50      Neuroprotective Agents/pharmacology       26          0.1968                        36.1414

  51      Oligodendroglia/cytology                  26          0.1968                        36.3382

  52      Cell and Tissue Based Therapy/methods     25          0.1892                        36.5274

  53      Brain Neoplasms/genetics                  25          0.1892                        36.7166

  54      Models, Biological                        25          0.1892                        36.9058

  55      Cell Lineage                              25          0.1892                        37.0951

  56      Brain/physiology                          25          0.1892                        37.2843

  57      Glioblastoma/genetics                     24          0.1817                        37.4659

  58      Hippocampus/cytology                      24          0.1817                        37.6476

  59      Induced Pluripotent Stem\                 24          0.1817                        37.8292
          Cells/transplantation                                                               

  60      Stem Cell Niche/physiology                23          0.1741                        38.0033

  61      Epigenesis, Genetic                       23          0.1741                        38.1774

  62      Astrocytes/physiology                     22          0.1665                        38.3439

  63      Cerebral Cortex/embryology                22          0.1665                        38.5104

  64      Brain Neoplasms/metabolism                22          0.1665                        38.6770

  65      Alzheimer Disease/pathology               22          0.1665                        38.8435

  66      Parkinson Disease/therapy                 21          0.1589                        39.0024

  67      Brain/embryology                          21          0.1589                        39.1614

  68      Brain/growth & development                21          0.1589                        39.3203

  69      Receptors, Notch/metabolism               20          0.1514                        39.4717

  70      Hippocampus/metabolism                    20          0.1514                        39.6231

  71      Signal Transduction/drug effects          20          0.1514                        39.7744

  72      Brain Neoplasms/therapy                   20          0.1514                        39.9258

  73      Spinal Cord/cytology                      20          0.1514                        40.0772

  74      Human Embryonic Stem Cells/cytology       19          0.1438                        40.2210

  75      Zika Virus/physiology                     19          0.1438                        40.3648

  76      Tissue Scaffolds/chemistry                19          0.1438                        40.5086

  77      Adult Stem Cells/metabolism               19          0.1438                        40.6524

  78      Induced Pluripotent Stem\                 19          0.1438                        40.7962
          Cells/pathology                                                                     
  -----------------------------------------------------------------------------------------------------------------------

![Biclustering analysis of 78 high-frequency main Medical Subject Heading (MeSH) terms/subheadings and articles on human neural stem cells from 2013 to 2018.\
(A) Mountain visualization of biclustering of 78 high-frequency main MeSH terms/subheadings and articles. (B) Matrix visualization of biclustering of 78 high-frequency main MeSH terms/subheadings and PubMed Unique Identifiers of the articles.](NRR-14-1823-g004){#F2}

###### 

Cluster analysis of high-frequency major Medical Subject Heading (MeSH) terms/subheadings of human neural stem cells

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cluster                                                                         Number of MeSH terms\*   Cluster analysis
  ------------------------------------------------------------------------------- ------------------------ -----------------------------------------------------------------------------
  0                                                                               31,75,65,54,44,\         1\. Neural stem cell pathology and virology
                                                                                  78,11,40,33,22,\         
                                                                                  57,53,48,64              

  2\. Brain neoplasm metabolism, pathology and genetics                                                    

  3\. Neoplastic stem cell metabolism and pathology                                                        

  1                                                                               47,73,25,6,9,1,\         1\. Neural stem cell cytology
                                                                                  30,28,10,49,55,\         
                                                                                  38,51,74,31              

  2\. Astrocyte, oligodendroglia, neuron, neural crest and spinal cord cytology                            

  3\. Cell culture techniques                                                                              

  2                                                                               27,18,60,56,63,\         1\. Neural stem cell physiology
                                                                                  4,3,14,36,62,58,\        
                                                                                  23,21,67,68              

  2\. Cell movement and proliferation physiology                                                           

  3\. Brain, neuron, astrocyte and neurogenesis physiology                                                 

  3                                                                               41,76,72,52,66,\         1\. Neural stem cells in Parkinson, stroke and spinal cord injuries therapy
                                                                                  8,5,34,59,26,17,\        
                                                                                  43,16,7,39,50,71         

  2\. Neural stem cell proliferation and differentiation by drug                                           

  3\. Tissue engineering                                                                                   

  4                                                                               32,29,13,15,20,\         1\. Neural stem cell metabolism
                                                                                  61,45,2,12,24,\          
                                                                                  35,70,77,37,42,\         
                                                                                  19,69                    

  2\. MicroRNA in neurogenesis and cell differentiation genetics                                           

  3\. Signal transduction and transcription factors                                                        
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Represents the number of high-frequency major MeSH terms/subheadings shown in [Additional Table 1](#T1){ref-type="table"}.

Theme trends of hNSCs {#sec2-8}
---------------------

With both high density and centrality, motor themes are located in the upper right of Quadrant I. Themes with high density but inadequate external interactions are defined as specialized themes in the upper left of Quadrant II. Themes with low density and centrality are usually considered either vanishing or emerging, and are located on the left of Quadrant III. The right part of Quadrant IV contains themes with weak internal maturation but high centrality (Viedma-Del-Jesus et al., 2011). In strategic diagrams, the themes are shown as roundness in different quadrants based on centralities and densities corresponding to external and internal cohesions.

The interpretation of the strategic diagram is presented in **[Figure 3A](#F3){ref-type="fig"}**. The clusters in Quadrant I, as central themes in the general network, are intensely connected with other clusters, with strong internal interactions (high development degree). The clusters in Quadrant II are peripheral but well developed themes, and those in Quadrant III are undeveloped and peripheral. However, the clusters in Quadrant IV are central but undeveloped, though they are slightly mature (Callon et al., 1991).

![Strategic diagrams for human neural stem cell (hNSC)-related research.\
(A) Meanings of the four quadrants in the strategic diagram. (B) Strategic diagram of hNSCs from 2013 to 2018. The size of a signal node represents the number of major Medical Subject Heading (MeSH) terms/subheadings involved in each cluster.](NRR-14-1823-g005){#F3}

The roundness area is proportional to the amount of high-frequency main MeSH terms/subheadings for each theme cluster (**[Figure 3B](#F3){ref-type="fig"}**). Clusters 1 and 2 in Quadrant I represent studies on NSC cytology (Cluster 1: astrocyte, oligodendroglia, neuron, neural crest and spinal cord cytology; cell culture techniques) and NSC biology (Cluster 2: cell movement and proliferation; brain, neuron, astrocyte and neurogenesis biology). These two clusters have core status and are well developed, with high density and centrality. Clusters 0 and 3 in Quadrant III represent studies on NSC pathology and virology (Cluster 0: brain neoplasm metabolism, pathology and genetics; neoplastic stem cell metabolism and pathology; Zika virus biology) and clinical applications of NSCs (Cluster 3: NSCs in Parkinson's, stroke and spinal cord injury therapy; tissue engineering; NSC proliferation and differentiation using drugs). These clusters are immature, *i.e*., at the edge of the hNSC research field. Cluster 4 in Quadrant IV represents studies on NSC metabolism and signaling (including microRNA in neurogenesis and cell differentiation genetics; signal transduction and transcription factors). It has core status, but is undeveloped. The diagram shows the development and tendency of each hNSC theme cluster in the 6-year period examined.

Knowledge structure of hNSCs {#sec2-9}
----------------------------

Degree, closeness and betweenness were used to build the social network analysis network knowledge structure as centrality parameters (**[Figure 4](#F4){ref-type="fig"}**). Furthermore, the social network analysis network was established on the basis of betweenness centrality. The node size was proportional to the betweenness centrality of main MeSH terms/subheadings, with the line thickness representing the frequency of co-occurrence.

![Social network structure map for main Medical Subject Heading (MeSH) terms/subheadings for human neural stem cell-related publications.\
Social network analysis for 78 main MeSH terms/subheadings from 2013 to 2018. Nodes represent MeSH terms/subheading words, while node size and location indicate the centrality of a word in the social network analysis map. Links represent the connection between two words, and the number or thickness of the lines indicates the co-occurrence frequency of the main MeSH terms/subheading pairs.](NRR-14-1823-g006){#F4}

In the network of hNSCs from 2013 to 2018, 23 main MeSH terms/subheadings (yellow and cyan circles in **[Figure 4](#F4){ref-type="fig"}**) had a high degree of centrality, including the top 15 high-frequency ones. Notably, "Neural Stem Cells/cytology" had the highest degree of centrality (1,110; **[Additional Table 1](#T1){ref-type="table"}**).

The top two highest betweenness centralities were 256.367 and 194.785 (**[Table 2](#T3){ref-type="table"}**), corresponding to "Neural Stem Cells/metabolism" and "Neural Stem Cells/cytology", respectively. They played the most significant mediating roles in the network. Furthermore, since both terms had the highest closeness values (76 and 73, respectively), they were tightly connected with other nodes. In addition to these two main MeSH terms/subheadings, "Cell Differentiation/physiology", "Neural Stem Cells/physiology", "Neurogenesis/physiology", "Neural Stem Cells/pathology", "Neurons/cytology", as well as "Neural Stem Cells/transplantation" also had high betweenness centralities, indicative of their prominent mediating roles in the network. The mean betweenness centrality was (24.769 ± 42.672; **[Table 3](#T4){ref-type="table"}**). Furthermore, 11 new nodes (magenta box in **[Figure 4](#F4){ref-type="fig"}**) at the network edge, including "Stroke/therapy", "Parkinson Disease/therapy", "Neural Crest/cytology", "MicroRNAs/genetics", "Neuroprotective Agents/pharmacology", "Glioblastoma/genetics", "Brain Neoplasms/genetics", "Epigenesis/genetics", "Receptors, Notch/metabolism", "Embryonic Stem Cells/metabolism" and "Zika Virus/physiology" were emerging hot topics of hNSC-related studies from 2013 to 2018 (**[Additional Table 2](#T5){ref-type="table"}**).

###### 

Individual centrality of human neural stem cells

  Rank   Major MeSH terms/MeSH subheadings           Degree   Betweenness   Closeness   Rank   Major MeSH terms/MeSH subheadings                Degree   Betweenness   Closeness
  ------ ------------------------------------------- -------- ------------- ----------- ------ ------------------------------------------------ -------- ------------- -----------
  1      Neural Stem Cells/cytology                  1110     194.785       73          40     Neoplastic Stem Cells/pathology                  79       11.251        49.333
  2      Neural Stem Cells/metabolism                842      256.367       76          41     Tissue Engineering/methods                       58       11.843        51.5
  3      Neural Stem Cells/physiology                452      134.478       69.5        42     Oligodendroglia/metabolism                       61       17.151        53
  4      Neurogenesis/physiology                     599      129.811       70          43     Cell Proliferation/drug effects                  50       4.010         46
  5      Neural Stem Cells/transplantation           323      60.345        61.5        44     Brain/pathology                                  54       15.211        52
  6      Cell Differentiation/physiology             520      142.634       70.5        45     Embryonic Stem Cells/metabolism                  53       3.258         47.5
  7      Neural Stem Cells/drug effects              174      23.598        55          46     Neural Crest/cytology                            45       1.530         45.5
  8      Stem Cell Transplantation/methods           277      50.231        60.5        47     Astrocytes/cytology                              80       24.205        53.5
  9      Neurons / cytology                          305      61.123        63.5        48     Neoplastic Stem Cells/metabolism                 57       2.554         45.833
  10     Induced Pluripotent Stem Cells/cytology     268      38.266        60          49     Cellular Reprogramming                           56       15.658        52
  11     Neural Stem Cells/pathology                 167      62.299        59.5        50     Neuroprotective Agents/pharmacology              35       5.436         47.5
  12     Neurons/metabolism                          190      29.496        57          51     Oligodendroglia/cytology                         65       6.441         50
  13     Cell Differentiation/genetics               140      34.307        56          52     Cell and Tissue Based Therapy/methods            52       3.571         47
  14     Neurons/physiology                          117      21.996        54.5        53     Brain Neoplasms/genetics                         43       1.630         44.5
  15     Neurogenesis/genetics                       116      32.762        57          54     Models, Biological                               50       14.189        52
  16     Neurogenesis/drug effects                   81       13.072        51          55     Cell Lineage                                     58       18.759        52.5
  17     Cell Differentiation/drug effects           123      14.689        52.5        56     Brain/physiology                                 52       2.727         46
  18     Cell Proliferation/physiology               127      19.831        54          57     Glioblastoma/genetics                            38       1.233         45
  19     Signal Transduction/physiology              116      37.024        57.5        58     Hippocampus/cytology                             54       3.885         47.5
  20     Gene Expression Regulation, Developmental   110      16.644        54.5        59     Induced Pluripotent Stem Cells/transplantation   45       1.570         45.5
  21     Brain/metabolism                            86       15.971        53          60     Stem Cell Niche/physiology                       51       4.660         47.5
  22     Glioblastoma/pathology                      120      26.545        54.5        61     Epigenesis, Genetic                              54       13.749        53
  23     Brain/cytology                              132      30.207        57.5        62     Astrocytes/physiology                            39       4.312         46.5
  24     Induced Pluripotent Stem Cells/metabolism   102      16.827        53.5        63     Cerebral Cortex/embryology                       36       0.593         44.5
  25     Pluripotent Stem Cells/cytology             120      18.106        54          64     Brain Neoplasms/metabolism                       47       7.712         48
  26     Spinal Cord Injuries/therapy                90       8.669         49.5        65     Alzheimer Disease/pathology                      44       8.162         49
  27     Cell Movement/physiology                    103      12.382        52          66     Parkinson Disease/therapy                        42       1.323         45.5
  28     Cell Culture Techniques/methods             124      26.299        55          67     Brain/embryology                                 42       4.015         48
  29     MicroRNAs/genetics                          85       15.685        51.5        68     Brain/growth & development                       43       2.273         47.5
  30     Embryonic Stem Cells/cytology               92       22.193        55          69     Receptors, Notch/metabolism                      48       5.737         48
  31     Neural Stem Cells/virology                  50       5.374         49          70     Hippocampus/metabolism                           41       4.590         47
  32     MicroRNAs/metabolism                        80       24.959        55.5        71     Signal Transduction/drug effects                 37       6.085         47.5
  33     Brain Neoplasms/pathology                   104      16.268        52          72     Brain Neoplasms/therapy                          28       1.492         44
  34     Stroke/therapy                              70       6.512         48.5        73     Spinal Cord/cytology                             51       9.501         50.5
  35     Nerve Tissue Proteins/metabolism            65       27.107        55          74     Human Embryonic Stem Cells/cytology              48       6.880         50
  36     Induced Pluripotent Stem Cells/physiology   61       13.069        51.5        75     Zika Virus/physiology                            29       0.772         44
  37     Transcription Factors/metabolism            63       11.35         52          76     Tissue Scaffolds/chemistry                       38       1.342         46
  38     Mesenchymal Stem Cells/cytology             61       3.810         47          77     Adult Stem Cells/metabolism                      33       2.372         45
  39     Neurons/drug effects                        45       2.520         45.667      78     Induced Pluripotent Stem Cells/pathology         28       2.711         45.5

###### 

Descriptive statistics for centrality measures for human neural stem cells

  Centralization   Mean ± SD         Min      Max        Network centralization (%)
  ---------------- ----------------- -------- ---------- ----------------------------
  Degree           124.026±174.513   28.000   1110.000   12.472
  Betweenness      24.769±42.672     0.593    256.367    8.020
  Closeness        52.248±6.825      44.000   76.000     62.910

###### 

Sub-categories of emerging hot topics

  No.   Emerging hot topics                   Sub-categories   Characteristics
  ----- ------------------------------------- ---------------- ----------------------------
  1     Zika Virus/physiology                 Cluster 0        Peripheral and undeveloped
  2     Neural Crest/cytology                 Cluster 1        Central and developed
  3     Stroke/therapy                        Cluster 3        Peripheral and undeveloped
  4     Parkinson Disease/therapy             Cluster 3        Peripheral and undeveloped
  5     Neuroprotective Agents/pharmacology   Cluster 3        Peripheral and undeveloped
  6     MicroRNAs/genetics                    Cluster 4        Central and undeveloped
  7     Glioblastoma/ genetics                Cluster 4        Central and undeveloped
  8     Brain Neoplasms/ genetics             Cluster 4        Central and undeveloped
  9     Epigenesis/ genetics                  Cluster 4        Central and undeveloped
  10    Receptors, Notch/metabolism           Cluster 4        Central and undeveloped
  11    Embryonic Stem Cells/ metabolism      Cluster 4        Central and undeveloped

Discussion {#sec1-4}
==========

NSCs in the central nervous system are capable of self-renewal and multi-potential differentiation. In recent years, NSC therapy has been used to treat many central nervous system diseases, aiming to inhibit or to reverse central nervous system damage. NSCs have been used in clinical practice mainly for direct cell transplantation therapy for central nervous system diseases, for gene delivery for gene therapy, and for modulating growth factors and cytokines for inducing self-differentiation for self-repair. These therapies have been used to treat Parkinson's disease, cerebrovascular disease, brain tumor, spinal cord injury and Alzheimer's disease (Boese et al., 2018; Ludwig et al., 2018; Mooney et al., 2018). Along with the increasing awareness of the potential clinical applications of hNSCs, hNSC-related studies have increased dramatically over the last 6 years, requiring a systematic analysis of knowledge structures and theme trends.

The PubMed database, one of the most important literature databases for the natural sciences, comprises more than 28,000,000 biomedical literature citations from journals in life science, MEDLINE and books online. In the present study, 2742 articles related to hNSCs were retrieved from the PubMed database, and the knowledge structure and progression in this field was investigated using biclustering analysis, co-word analysis, social network analysis and strategic diagram plotting. It is the first time that this method has been used to analyze the research trends of hNSCs in this 6-year period.

The United States ranked first in the number of publications on hNSC-related studies. Among the top 15 journals, it is notable that *PLoS One* has been far ahead, with 130 papers. In addition, *Stem Cell Reports* and *Scientific Reports* were the other major journals publishing hNSCs-related papers. Thus, major future developments in the field of hNSCs will likely be published by these three journals.

To methodically analyze the basic knowledge of hNSCs, we integrated social network analysis with co-word analysis. From co-word analysis, closely-related MeSH terms were grouped into clusters.

Cluster 1 is mainly related to the cytology of hNSCs (including astrocyte, oligodendroglia, neuron, neural crest and spinal cord cytology, and cell culture techniques). NSCs are generated through asymmetric division into neural precursor cells, followed by the same type of division into new functional neurons. The processes occur both in the adult central nervous system and during embryonic neural development. After isolation from primary tissues, NSCs can be cultured under nonadherent conditions in vitro, giving clonally-derived colonies (neurospheres). These cells can also be cultured as two-dimensional adherent monolayers (Adams and Morshead, 2018). NSCs can be differentiated from induced pluripotent stem cells from neurological patients as well as healthy individuals by treatment with small molecules, specific transcription factors, plasmids, microRNAs and other morphogens (Iván Velasco et al., 2014; Leonardo D'Aiuto et al., 2014). Moreover, NSCs can be produced from embryonic stem cells originating from blastocysts by treatment with extracellular matrix proteins, morphogens and other differentiation factors (Bergström and Forsberg-Nilsson, 2012). Human NSCs can be expanded in defined media containing growth factors such as basic fibroblast growth factor and epidermal growth factor, and thereafter cultured as free-floating neurospheres or monolayers (Villa et al., 2000). Li et al. (2016) reported that transduction with L-Myc (LM-NSC008) maintains the self-renewal capacity and multipotency of primary hNSCs. The immortalization with Myc was typified by long-term expansion and karyotype stability.

Cluster 2 is mainly related with the biology of hNSCs (including cell movement and proliferation, as well as brain, neuron, astrocyte and neurogenesis). In the adult mammalian brain, NSCs are located in the hippocampal subgranular zone, lateral ventricular subgranular zone and central canal of the spinal cord. These cells divide and generate new neurons in a process referred to as adult neurogenesis (Yuan et al., 2015). Although hippocampal neurogenesis is sharply attenuated with age (Sorrells et al., 2018), accumulating evidence shows that neurogenesis persists in the striatum (Ernst et al., 2018) and hippocampus (Spalding et al., 2013; Boldrini et al., 2018) in humans over their lifetime. Though neurogenesis takes place at a very low rate in healthy adult mammals, it can be stimulated by central nervous system injury (Yu et al., 2016). NSCs and neurogenic niches have been reported to exist in the central nervous system of adult mammals. Given their critical roles in health and disease, neurogenesis and gliogenesis have been studied extensively. The niche microenvironment regulates NSC survival, proliferation and differentiation under healthy and disease conditions (Pourabdolhossein et al., 2017). For example, NSC proliferation is enhanced by administration of exogenous growth factors such as ciliary neurotrophic factor, hepatocyte growth factor and epidermal growth factor (Ramírez-Castillejo et al., 2006). Clusters 1 and 2 are located in Quadrant I, and are therefore hot research topics that are well developed and centralized.

Cluster 0 is mainly associated with the pathology of NSCs and brain tumors (including brain neoplasm metabolism, pathology and genetic, neoplastic stem cell metabolism and pathology, and Zika virus biology). The stem cell-like cells in brain tumors have been identified and isolated in vitro, although whether these behaviors are associated with their *in vivo* functions remains unclear (Galli et al., 2004; Singh et al., 2004). As tumor-tropic cells, NSCs can rapidly penetrate normal organs and target metastatic and invasive tumor foci, and reach brain tumors after traversing the blood-brain barrier (Aboody et al., 2013). A first-in-human pilot safety/feasibility study of NSCs, initiated in 2010 (NCT01172964), showed that NSCs can migrate to distant tumors sites and are non-tumorigenic, thereby demonstrating the safety and ability of NSCs to target tumor foci in the brain for localized chemotherapies (Portnow et al., 2017). Clearly, every NSC source (pool or clone) must be tested for functional and genetic stabilities with increasing passage and time, together with tumor tropism, before clinical use. Notably, the allogeneic clonal HB1.F3.CD NSC line, which is chromosomally stable, has well-documented non-tumorigenicity (Mooney et al., 2018). Now, effective methodologies are needed to image the biodistribution of NSCs in patients. Bhagat et al. (2018) demonstrated that expression of the Zika virus envelope (E) protein leads to the accumulation of hNSCs in the G0/G1 phase of the cell cycle, thereby reducing the brain cell pool and causing microcephaly.

Cluster 3 is mainly related to the clinical applications of hNSCs (including NSCs in Parkinson's, stroke and spinal cord injure therapy, tissue engineering, and NSC proliferation and differentiation using drugs). The aim of NSC-related studies is to develop medical interventions and therapeutic strategies to recover the function and structure of the injured nervous system. As shown by pre-clinical proof-of-concept studies, NSC-based therapies provide protection against insults (Umeda et al., 2016), and can be used for neuronal replacement (Begum et al., 2015), the production of antibodies (Kanojia et al., 2015) and the targeted delivery of therapeutic agents (Aboody et al., 2013), including prodrug-activating enzymes (Metz et al., 2013). ReNeuron has developed an hNSC-based therapy for post-stroke chronic disability on the basis of early clinical studies (clinicaltrials.gov NCT02117635). In addition, the CTX0E03 cell line from ReNeuron has been assessed in a single-center first-in-human trial of patients with moderate or severe disability 6 months to 5 years after ischemic stroke. The study revealed therapeutic potential, without safety concerns (Kalladka et al., 2016). At present, a Phase II multi-center trial of cases of upper limb disability 3--12 months after stroke is ongoing in the United Kingdom (clinicaltrials.gov NCT02117635). These studies have helped clarify the functional role of NSCs under normal and pathological conditions, as well as the challenges to their use in neural repair.

Clusters 0 and 3 in Quadrant III are existing hot topics that are undeveloped and peripheral, requiring further in-depth studies.

Cluster 4 is mainly linked to the metabolism and signaling transduction pathways of NSCs (including microRNAs in neurogenesis and cell differentiation, signal transduction and transcription factors). NSCs may integrate various homeostatic signals to modulate cellular biology on multiple levels to produce an optimal metabolic response (Knobloch and Jessberger, 2017; Ferreira et al., 2018). During neuronal differentiation, various signaling effectors, including Notch, Sonic hedgehog, bone morphogenetic proteins and Wnt, together with transcription factors such as Sox2, Nanog and Oct4, participate in regulating the pluripotentiality of NSCs (Gkikas et al., 2017; Navarro Quiroz et al., 2018). To date, over 2500 human miRNAs have been identified, and most are expressed in the brain (Shao et al., 2010). The modulating effects of microRNAs on the activities and characteristics of NSCs have been extensively studied. For example, miR-410 (Tsan et al., 2016), miR-9 (Radhakrishnan et al., 2016) and let-7a (Song et al., 2016) have been shown to be involved in NSC differentiation, and miR-184 and miR-134 have been found to participate in progenitor maintenance and the proliferation of neurons (Bian et al., 2013). Furthermore, miR-338-3p (Howe et al., 2017) and the miR-200 family (Beclin et al., 2016) are involved in neuronal maturation and neurogenesis. Connecting miRNAs with specific functions during neural development in humans will help clarify pathological and physiological processes in the central nervous system. In this study, this cluster in Quadrant IV suggests that these current hot topics are undeveloped and centralized.

Here, social network analysis showed that the top six high-frequency MeSH terms also had high degrees of centrality. MeSH terms such as "Neural Stem Cells/metabolism" had maximum direct links to other components and promoted the development of hNSC-related research. For betweenness centrality, "Neural Stem Cells/cytology", "Neural Stem Cells/metabolism", "Cell Differentiation/physiology", "Neural Stem Cells/physiology", "Neurons/cytology", "Neurogenesis/physiology", "Stem Cell Transplantation/methods" and "Induced Pluripotent Stem Cells/cytology" were located at the center of the entire network, indicating that the dominant components were most capable of regulating the co-occurrence of others. Therapy and genetics-related hot topics were along the network edge. Thus, while the cytology and physiology of hNSCs have been widely studied, NSC-related therapeutic and genetic topics are emerging research fields.

The current study is the first to comprehensively analyze hNSC-related publications using bibliometrics. Our results show that hNSCs are still in the primary development stages but have great potential for future applications. Forthcoming studies should focus on the emerging hot spots and undeveloped topics.

There are a few limitations to the present study. First, we only included journal articles, and excluded reviews and other types of literature. Because reviews were excluded, some hot research topics may be missing. Second, the articles and journals were all in English, and therefore, the exclusion of non-English papers may have affected the conclusions. Third, the co-word analysis was performed on the basis of high-frequency MeSH terms, which may have affected the results of clustering analysis, and therefore, some emerging topics may have been missed. Thus, in future studies, analyses combining new emerging topics and multiple databases should be conducted.

In summary, biclustering analysis, social network analysis and strategic diagram were performed on the basis of co-word analysis of high-frequency MeSH terms for hNSCs. Undeveloped themes, such as the application of NSCs, tissue engineering, signal transduction, microRNA, NSC pathology and virology, can be considered attractive for future studies. Furthermore, cytology, physiology, metabolism and cell signaling are core themes that have experienced sustained development from 2013 to 2018. NSC therapy for stroke and Parkinson's disease, the genetics of microRNAs, brain neoplasms and epigenesis, as well as neuroprotective agents, neural crest, embryonic stem cells, Zika virus and Notch receptor are emerging hot spots. Our findings should help provide guidance to scientists and clinicians planning hNSC-related research projects.
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